Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-25 @ 2:37 AM
NCT ID:
NCT04109534
Eligibility Criteria:
Inclusion Criteria:
* Informed consent
* Patients: aged ≥18 and 45 years
* known allergen induced asthma and HDM-Allergy
* basic lung function FVC ≥ 80%, FEV1 ≥ 75%
* decrease in FEV1 after BAP ≥ 20%
* 30% increase of NO after BAP
Exclusion Criteria:
* lung function Forced vital capacity (FVC) \<80% and Forced expiratory volume in 1 second (FEV1) \<75%
* chronic diseases or infections (e.g. HIV, Tbc)
* pregnancy
* systemic corticosteroid-treatment
* inhalative corticosteroid therapy or leukotriene antagonists
* alcohol, substance or drug abuse
* current smokers
* inability to capture extend and consequences of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT04109534
Study Brief:
Protocol Section:
NCT04109534